RECURRENT BLADDER CANCER

Clinical trials for RECURRENT BLADDER CANCER explained in plain language.

Never miss a new study

Get alerted when new RECURRENT BLADDER CANCER trials appear

Sign up with your email to follow new studies for RECURRENT BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

Targeted pill tested to shrink recurrent bladder tumors before surgery

Disease control Ongoing

This study is testing whether a pill called erdafitinib can shrink recurrent bladder tumors that have a specific genetic change (FGFR3 mutation). The pill is taken by mouth and aims to block a protein that helps the cancer grow. Researchers want to see if giving this pill in the …

Matched conditions: RECURRENT BLADDER CANCER

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:15 UTC

RECURRENT BLADDER CANCER

Get alerted when new RECURRENT BLADDER CANCER trials appear

Targeted pill tested to shrink recurrent bladder tumors before surgery